Imperial Brands Sees Flat 1st Half Profit; On Track to Meet Full-Year Guidance — Update
By Kyle Morris
Imperial Brands PLC said Thursday that it is on track to meet 2023 guidance, and that first-half adjusted group operating profit should be roughly flat on year on a constant-currency basis.
The tobacco group said that, excluding the impact of its exit from Russia, first-half group net revenue is seen at a similar level to the prior-year period at constant currency, with strong combustible pricing offset by volume declines as the prior period benefited from Covid-19-related changes in buying patterns. It sees a stronger net revenue performance in the second half, driven by normalization of volume trends.
For the full year, the company sees low single-digit constant currency net revenue growth, in line with expectations.
First-half group adjusted operating profit is expected to be at a similar level to last year on a constant currency basis.
For the first half of 2022, revenue was 15.36 billion pounds ($19.18 billion) and adjusted operating profit was GBP1.59 billion.
Aggregate share in its top five markets at the half year is anticipated at a similar level to the prior period. The U.S., Spain and Australia are anticipated to show growing or stable market share, offsetting declines in Germany and the U.K.
First-half next generation products revenue is expected ahead of the prior-year period, driven by strong growth in Europe and offsetting a decline in the U.S. mainly related to uncertainty caused by the marketing denial order for myblu.
Foreign exchange is expected to be an around 6.5% tailwind on first-half earnings per share, and a roughly 2.5%-3.5% tailwind on full-year earnings per share.
Write to Kyle Morris at kyle.morris@dowjones.com
(END) Dow Jones Newswires
April 13, 2023 03:18 ET (07:18 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth